Novo Nordisk’s Vikrant Shrotriya on accelerating Wegovy’s launch, pricing strategy, and building long-term obesity care ...

Apollo’s Health of the Nation 2025 report reveals a sharp rise in obesity, diabetes, hypertension, and vitamin deficiencies ...

The focus of Poshan Pakhwada this year is to combat malnutrition through behavior changes, highlighting the importance of ...

Union Minister Savitri Thakur expressed alarm about childhood obesity today, Tuesday, April 8, stating that overnutrition and ...

North America Leads the Market: In 2022, North America accounted for approximately 32% of the global revenue, making it the dominant region in the kidney stone extraction balloon market. The growth is ...

Although the risk of striking breast cancer to teenagers is slightly low, yet it can occur in any age. However it is most ...

The Obesity Society is disappointed with the decision made by the Centers for Medicare and Medicaid Services (CMS) to continue its policy that restricts access to safe and effective obesity ...

Given this unsavory state of affairs, it is worth noting that in some developing nations, obesity can actually help individuals from an economic standpoint. This interesting and somewhat ...

Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with weight management and activates hormone receptors.

“The dual burden of obesity and type 2 diabetes is rapidly emerging as a major public health challenge in India. Lilly is committed to collaborating with the government and industry to promote ...